COMPOSITIONS, DEVICES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCERS

• 收藏
• 分享

专利权人:

INTARCIA THERAPEUTICS; INC.

发明人:

LEUNG, KARLING ALICE

申请号：

CA2823721

公开号：

CA2823721A1

申请日:

2012.02.14

申请国别(地区):

CA

年份:

2012

代理人:

摘要：

The use of GLP-1 receptor agonists, such as glucagon-like peptide- 1 (GLP-1) or exenatide, for the treatment of cancer is described. The GLP-1 receptor agonists are typically delivered using an implanted osmotic delivery device that provides for continuous delivery of the GLP-1 receptor agonist for at least one month. Additional beneficial agents, such as anticancer agents, can also be administered.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/